bibliographic entry 5530278 [be/5530278]
https://w3id.org/oc/corpus/be/5530278

is a

• bibliographic reference

content

• Bristol-Myers Squibb. Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response (DASFREE). In: ClinicalTrials.gov [Internet]. Bethesda (MD):National Library of Medicine (US). Available at https://clinicaltrials.gov/ct2/show/NCT01850004 NLM Identifier: NCT01850004. 2015.

references

• https://w3id.org/oc/corpus/br/4866066